Publications

5808 Results

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104 [PMID20368559; PMC288173]

Authors
AH Partridge;L Archer;AB Kornblith;J Gralow;D Grenier;E Perez;AC Wolff;X Wang;H Kastrissios;D Berry;C Hudis;E Winer;M Muss
Journal / Conference
Journal of Clinical Oncology 28(14):2418-2422
Year
2010
Research Committee(s)
Breast

Does microgranular variant morphology of acute promyelocytic leukemia independently predict for a less favorable outcome compared with classical M3 APL? A joint study of North American Intergroup and PETHEMA Group [PMID20858857;PMC3031411]

Authors
M Tallman;HT Kim;P Montesinos;F Appelbaum;J de la Serna;JM Bennett;G Deben;C Bloomfield;J Gonzalez;JH Feusner;M Gonzalez;RA Larson;J Gonzalez-San Miguel;A Ogden;G Milone;JM Rowe;C Rayon;L Shepherd;C Rivas;CA Schiffer;E Vallenga;PH Wiernik;CL Willman;MA Sanz
Journal / Conference
Blood 116(25):5650-5659
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Multivitamin use is not associated with cancer recurrence or survival in patients with Stage III colon cancer: findings from CALGB 89803 [PMID20805450; PMC2954134]

Authors
K Ng;JA Meyerhardt;JA Chan;D Niedzwiecki;DR Hollis;LB Saltz;RJ Mayer;AB Benson;PL Schaefer;R Whittom;A Hantel;RM Goldberg;C Fuchs
Journal / Conference
Journal of Clinical Oncology, 28(29):4354-4363;
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy (TRT) as definitive treatment for locally advanced, unresectable esophageal cancer (Ec): a SWOG (S0414) phase II trial

Authors
CR Thomas;B Goldman;J Benedetti;H Lenz;T Beeker;JL Abbruzzese;C Blanke
Journal / Conference
ASCO 2010 Gastrointestinal Cancers Symposium, abst. #72; poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0414

Do mixed histologic features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?

Authors
EM Messing;E Scosyrev;HB Grossman;R de Vere White;DL Trump;RB Natale;C Tangen;ED Crawford;IM Thompson
Journal / Conference
ASCO 2010 Genitourinary Cancers Symposium, abstr. #274; oral
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therappy (RT) in locally advanced prostate cancer (CAP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)

Authors
PR Warde;MD Mason;MR Sydes;M Gospodarowicz;GP Swanson;P Kirkbride;E Kostashuk;J Hetherington;K Ding;W Parulekar
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr CRA4504); oral presentation
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
JPR3

ECOG 2204: An intergroup phase II study of cetuxamab (Ce) or bevacizumab (B) in combination with gemcitabine (G) and in combination with capecitabine (Ca) and radiation (XRT) as adjuvant therapy (Adj Tx) for patients (pts) with completely resected pancreatic adenocarcinoma (PC)

Authors
J Berlin;PJ Catalano;Y Feng;AM Lowy;AW Blackstock;PA Philip;RR McWilliams;J Abbruzzese;AB Benson
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 4024) poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/E2204

E4697: Phase III cooperative group study of yeast-derived granulocyte macrophage colony-stimulating factor (GM-CSF) versus placebo as adjuvant treatment of patients with completely resected stage III-IV melanoma

Authors
DH Lawson;SJ Lee;AH Tarhini;K Margolin;M Ernstoff;JM Kirkwood
Journal / Conference
Journal of Clinical Oncology 28:7s(suppl; abstr 8504); oral presentation
Year
2010
Research Committee(s)
Melanoma
Study Number(s)
E4697

Sorafenib in patients with platinum treated extensive stage small cell lung cancer (SCLC): A Southwest Oncology Group (SWOG 0435) phase II trial

Authors
B Gitlitz;J Moon;B Glisson;H Reimers;M Bury;J Floyd;TK Schulz;PK Sundaram;C Ho;D Gandara
Journal / Conference
Journal of Thoracic Oncology, Nov; 5(11):1835-1840;
Year
2010
Research Committee(s)
Lung
PMID
PMID20881645
PMC
PMC3676180
Study Number(s)
S0435

Objective response rate of unresectable benign meningioma to hydroxyurea: Southwest Oncology Group phase II trial S9811

Authors
L Swinnen;C Rankin;EJ Rushing;L Hutchins;D Damek;G Barger
Journal / Conference
Society of Neuro-Oncology 2010 Annual Scientific Meeting; poster presentation
Year
2010
Research Committee(s)
Brain
Study Number(s)
S9811